0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Study |

Improving Management and Patient Care in Lentigo Maligna by Mapping With In Vivo Confocal Microscopy

Pascale Guitera, MD, PhD; Fergal J. Moloney, MD; Scott W. Menzies, MBBS, PhD; Jonathan R. Stretch, MBBS, DPhil; Michael J. Quinn, MBBS; Angela Hong, MBBS, PhD; Gerald Fogarty, MBBS; Richard A. Scolyer, MD
JAMA Dermatol. 2013;149(6):692-698. doi:10.1001/jamadermatol.2013.2301.
Text Size: A A A
Published online

Importance Lentigo maligna (LM) is a clinical, pathologic, and therapeutic challenge with a higher risk of local recurrence than other types of melanoma correctly treated and also carries the cosmetically sensitive localization of head and neck.

Objective To determine whether in vivo reflectance confocal microscopy (RCM) mapping of difficult LM cases might alter patient care and management.

Design Analysis of LM and LM melanoma (LMM) in a series of patients with large facial lesions requiring complex reconstructive surgery and/or recurrent or poorly delineated lesions at any body sites were investigated.

Settings Two tertiary referral melanoma centers in Sydney, Australia.

Participants Thirty-seven patients with LM (including 5 with LMM) were mapped with RCM. Fifteen patients had a recurrent LM, including 9 with multiple prior recurrences. The LM was classified amelanotic in 10 patients, lightly pigmented in 9, and partially pigmented in 18.

Interventions The RCM images were obtained in 4 radial directions (allowing for anatomic barriers) for LM margin delineation using an RCM LM score previously described by our research team.

Main Outcome Measures Differences in the margin of LM as determined by RCM vs dermoscopy vs histopathologic analysis.

Results Seventeen of 29 patients (59%) with dermoscopically visible lesions had subclinical (RCM-identified) disease evident more than 5 mm beyond the dermoscopy margin (ie, beyond the excision margin recommended in published guidelines). The RCM mapping changed the management in 27 patients (73%): 11 patients had a major change in their surgical procedure, and 16 were offered radiotherapy or imiquimod treatment as a consequence of the RCM findings. Treatment was surgical in 17 of 37 patients. Surgical excision margins (based on the RCM mapping) were histopathologically involved in only 2 patients, each of whom had an LM lesion larger than 6 cm.

Conclusions and Relevance In vivo RCM can provide valuable information facilitating optimal patient care management.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. An 88-year-old man presented with macular pigmentation of the left cheek that had developed over many years. Purple lines indicate the length and width of the visible pigmentation. Yellow lines indicate the length and width of the tumor as determined by reflectance confocal microscopy (RCM). The center of 4 pen marks on the patient's skin indicates the site of biopsy. Areas examined by RCM correspond with the numbers on the image. This patient was surgically treated with complete excision (guided by RCM mapping), and no recurrence was found at 4-year follow-up. ND indicates not done; Pathol, pathologic assessment; +, diagnosed as lentigo maligna; −, diagnosed as negative margin.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. A 78-year-old woman with extensive pigmentation of her left cheek, 8 areas of which were examined by reflectance confocal microscopy (RCM). The area of lentigo maligna (LM) is delineated with the black line. The area mapped by RCM was excised, but a margin at the lower eyelid area was positive for LM. Subsequent re-excision of this margin was undertaken with no recurrence (at 18 months' follow-up). The facial areas marked X, Y, and Z are further illustrated in Figures 3, 4, and 5, each figure showing dermoscopic, RCM, and histopathologic images (histopathologic specimens taken from the RCM field). The facial area marked X showed atypical features of LM under all 3 evaluation techniques; the area marked Y is a negative margin; and the area marked Z showed features of an actinic lentigo.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 3. Images corresponding to area X in Figure 2. A, Dermoscopy image of the area of biopsy-proven lentigo maligna (LM). There are some areas of slate-gray globules and rhomboidal structures, and there are some asymmetric pigmented follicular structures (upper arrow). The lower arrow indicates artifact from a previous punch biopsy. B, Reflectance confocal microscopy (RCM) 8 × 8-mm mosaic at the dermoepidermal junction showing some atypical melanocytic cells and the distortion of the dermoepidermal junction (inset, detail of an RCM image, 0.5 × 0.5 mm, showing numerous bright, large [>20 μm], irregularly shaped cells [arrows] with a complete disorganization of the junction [nonedged papillae). C, Hematoxylin-eosin–stained specimen from the RCM field showing a lentiginous proliferation of atypical melanocytes with involvement of a skin appendage in chronically sun-damaged skin (original magnification ×100). These features are characteristic of LM.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 4. Images corresponding to area Y in Figure 2. A, Dermoscopy image showing ill-defined pigmentation with no clear feature of lentigo maligna (LM). B, Confocal image, 0.5 × 0.5 mm, showing a continuous layer of small monomorphous cells that are not very bright at the spinous layer. C, Hematoxylin-eosin–stained specimen from the RCM field showing atrophic epidermis with loss of rete ridges and severe dermal solar elastosis; there is mild patchy basal keratinocyte pigmentation but no evidence of LM (original magnification ×100).

Place holder to copy figure label and caption
Graphic Jump Location

Figure 5. Images corresponding to area Z in Figure 2. A, Dermoscopy image showing poorly formed rhomboidal structures. B, Confocal image, 0.5 × 0.5 mm, showing some bright cells but not bigger than the surrounding keratinocytes (arrows); the honeycomb pattern of the keratinocytes is mildly distorted. C, Hematoxylin-eosin–stained specimen from the RCM field showing an actinic lentigo with increased basal keratinocyte pigmentation, elongated rete ridges, and focal mild keratinocyte atypia. There is no increase in melanocytes (original magnification ×100).

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();